In vitro reactivation of the FMR1 gene involved in fragile X syndrome

Human Molecular Genetics

Volumn 7, Issue 1, 1998, Pages 109-113

  Chiurazzi, Pietro ^a   Pomponi, M Grazia ^a   Willemsen, Rob ^b   Oostra, Ben A ^b   Neri, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYTOSINE; MESSENGER RNA;

ARTICLE; CHROMOSOME XQ; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; FRAGILE X SYNDROME; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTELLIGENCE QUOTIENT; LYMPHOBLASTOID CELL; MALE; MENTAL DEFICIENCY; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS;

EID: 0031985868     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.1.109     Document Type: Article

References (28)

1. Oostra, B.A. and Willems P.J. (1995) A fragile gene. BioEssays, 17, 941-947.
2. Verkerk, A.J.M.H., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P.A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F., Eussen, B.E., van Ommen, G.J.B., Blonden, L.A.J., Riggins, G.J., Chastain, J.L., Kunst, C.B., Galjaard, H., Caskey, C.T., Nelson, D.L., Oostra, B.A. and Warren, S.T. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
3. Fu, Y.H., Kuhl, D.P.A., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J.M.H., Holden, J.J.A., Fenwick, R.G., Warren, S.T., Oostra, B.A., Nelson, D.L. and Caskey, C.T. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058
4. Luo, S., Robinson, J.C., Reiss, A.L. and Migeon, B.R. (1993) DNA methylation of the fragile X locus in somatic and germ cells during fetal development: relevance to the fragile X syndrome and X inactivation. Somat. Cell. Mol. Genet., 19, 393-404.
5. Hansen, R.S., Gartler, S.M., Scott, C.R., Chen, S.H. and Laird, C.D. (1992) Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum. Mol. Genet., 1, 571-578.
6. Pieretti, M., Zhang, F., Fu, Y.H., Warren, S.T., Oostra, B.A., Caskey, C.T. and Nelson, D.L. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66, 817-822.
7. Sutcliffe, J.S., Nelson, D.L., Zhang, F., Pieretti, M., Caskey, C.T., Saxe, D. and Warren, S.T. (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet., 1, 397-400.
8. Verheij, C., Bakker, C.E., de Graaff, E., Keulemans, J., Willemsen, R., Verkerk, A.J., Galjaard, H., Reuser, A.J., Hoogeveen, A.T. and Oostra. B.A. (1993) Characterization and localization of the FMR1 gene product associated with fragile X syndrome. Nature, 363, 722-724.
9. Hwu, W.L., Lee, Y.M., Lee, S.C. and Wang, T.R. (1993) In vitro DNA methylation inhibits FMR1 promoter. Biochem. Biophys Res. Commun., 193, 324-329.
10. Sandberg, G. and Schalling, M. (1997) Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression. Nucleic Acids Res., 25, 2883-2887.
11. Smeets, H.J.M., Smits, A.P.T., Verheij, C.E., Theelen, J.P.G., Willemsen, R., van de Burgt, I., Hoogeveen, A.T., Oosterwijk, J.C. and Oostra, B.A. (1995) Normal phenotype in two brothers with a full FMR1 mutation. Hum. Mol. Genet., 4, 2103-2108.
12. de Vries, B.B.A., Jansen, C.C.A.M., Duits, A.A., Verheij, C., Willemsen, R., van Hemel, J.O., van den Ouweland, A.M.W., Niermeijer, M.F., Oostra, B.A. and Halley, D.J.J. (1996) Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J. Med. Genet., 33, 1007-1010.
13. Wang, Z., Taylor, A.K. and Bridge, J.A. (1996) FMR1 fully expanded mutation with minimal methylation in a high functioning fragile X male. J. Med. Genet., 33, 376-378.
14. Hagerman, R.J., Hull, C.E., Safanda, J.F., Carpenter, I., Staley, L.W., O'Connor, R.A., Seydel, C., Mazzocco, M.M., Snow, K., Thibodeau, S.N., Kuhl, D., Nelson, D.L., Caskey, C.T. and Taylor, A.K. (1994) High functioning fragile X males: demonstration of an unmethylated fully expanded FMR1 mutation associated with protein expression. Am. J Med. Genet., 51, 298-308.
15. McConkie-Rossell, A., Lachiewicz, A.M., Spiridigliozzi, G.A., Tarleton, J., Schoenwald, S., Phelan, M.C., Goonewardena, P., Ding, X. and Brown, W.T. (1993) Evidence that methylation of the FMR-1 locus is responsible for variable phenotypic expression of fragile X syndrome. Am. J. Hum. Genet., 53, 800-809.
16. Rousseau, F., Robb, L.J., Rouillard, P. and Der Kaloustian, V.M. (1994) No mental retardation in a man with 40% abnormal methylation at the FMR1 locus and transmission of sperm cell mutations as premutations. Hum. Mol. Genet., 3, 927-930.
17. Loesch, D.Z., Muggins, R., Hay, D.A., Gedeon, A.K., Mulley, J.C., Sutherland, G.R. (1993) Genotype-phenotype relationships in fragile X syndrome: a family study. Am. J. Hum. Genet., 53, 1064-1073.
18. de Graaff, E., Willemsen, R., Zhong, N., de Die-Smulders, C.E.M., Brown, W.T., Freling, G. and Oostra, B. (1995) Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am. J. Hum. Genet., 57, 609-618.
19. Sasaki, T., Hansen, R.S. and Gartler, S.M. (1992) Hemimethylation and hypersensitivity are early events in transcriptional reactivation of human inactive X-linked genes in a hamster x human somatic cell hybrid. Mol. Cell. Biol., 12, 3819-3826.
20. Hansen, R.S. and Gartler, S.M. (1990) 5-Azacytidine induced reactivation of the human X chromosome-linked PGK1 gene is associated with a large region of cytosine demethylation in the 5′ CpG island. Proc. Natl Acad. Sci. USA, 87, 4171-4178.
21. Hansen, R.S., Canfield, T.K., Fjeld, A.D. and Gartler, S.M. (1996) Role of late replication timing in the silencing of X-linked genes. Hum. Mol. Genet., 5, 1345-1353.
22. Feng, Y., Zhang, F., Lokey, L.K., Chastain, J.L., Lakkis, L., Eberhart, D. and Warren, S.T. (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science, 268, 731-734.
23. Lowrey, C.H. and Nienhuis, A.W. (1993) Treatment with azacitidine of patients with end stage β-thalassemia. New Engl. J. Med., 329, 845-848.
24. Neitzel H. (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet., 73, 320-326.
25. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
26. Muellenbach, R., Lagoda, P.J.L. and Welter, C. (1989) An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet., 5, 391.
27. Nakahori, Y., Knight, S.J., Holland, J., Schwartz, C., Roche, A., Tarleton, J., Wong, S., Flint, T.J., Froster-Iskenius, U., Bentley, D., Davies, K.E. and Hirst, M.C. (1991) Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Res., 19, 4355-4359.
28. Willemsen, R., Mohkamsing, S., de Vries, B., Devys, D., van den Ouweland, A., Mandel, J.L., Galjaard, H. and Oostra, B.A. (1995) Rapid antibody test for fragile X syndrome. Lancet, 345, 1147-1148.